Skip to main content

About Mark Towler

Dr. Towler was previously a professor of biomedical engineering at Toronto Metropolitan University (formerly Ryerson University). He was also an affiliate scientist with St. Michael’s Hospital in Toronto and created two companies: Crescent Operations and Solas Operations. He invented a diagnostic device that can indicate a person’s risk of bone fracture by analyzing their nail clipping. The device launched in the United Kingdom in 2016 and will launch in Canada in 2023. Dr. Towler is recognized for publishing the first paper identifying the relationship between nail structure and bone. He holds eight granted patents in the medical devices space. Prior to his time at Toronto Metropolitan, Towler served as Inamori Professor of Biomaterials at Alfred University in Alfred, New York. Before that, he was a senior lecturer and research scholar at the University of Limerick in Ireland. He was also a research-and-development scientist with Advanced Healthcare, Ltd. in Kent, England. 

New Faculty 2023-2024
Bio-X Researcher

Positions

Present Doshi Professor, Missouri University of Science and Technology
to


$
to
Enter a valid date range.

to
Enter a valid date range.

Research Works (171)